Stock DNA
Pharmaceuticals & Biotechnology
HKD 2,351 Million ()
47.00
NA
0.00%
-0.04
-999,999.00%
2.17
Revenue and Profits:
Net Sales:
176 Million
(Quarterly Results - Jun 2010)
Net Profit:
14 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.17%
0%
-12.17%
6 Months
3.09%
0%
3.09%
1 Year
33.5%
0%
33.5%
2 Years
175.26%
0%
175.26%
3 Years
203.41%
0%
203.41%
4 Years
242.31%
0%
242.31%
5 Years
0%
0%
0.0%
JBM (Healthcare) Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.46%
EBIT Growth (5y)
23.06%
EBIT to Interest (avg)
14.65
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
70.18
Tax Ratio
37.67%
Dividend Payout Ratio
70.60%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
47
Industry P/E
Price to Book Value
2.25
EV to EBIT
29.43
EV to EBITDA
27.04
EV to Capital Employed
2.30
EV to Sales
3.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.82%
ROE (Latest)
4.79%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'10 - YoY
Jun'10
Jun'09
Change(%)
Net Sales
176.20
170.30
3.46%
Operating Profit (PBDIT) excl Other Income
24.50
15.50
58.06%
Interest
1.40
1.60
-12.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.30
9.00
58.89%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2010 is 3.46% vs 5.97% in Jun 2009
Consolidated Net Profit
YoY Growth in quarter ended Jun 2010 is 58.89% vs 125.00% in Jun 2009
Annual Results Snapshot (Consolidated) - Mar'23
Mar'23
Mar'22
Change(%)
Net Sales
520.30
406.10
28.12%
Operating Profit (PBDIT) excl Other Income
111.40
84.10
32.46%
Interest
8.20
6.40
28.12%
Exceptional Items
5.10
-2.50
304.00%
Consolidate Net Profit
63.30
23.30
171.67%
Operating Profit Margin (Excl OI)
130.20%
89.50%
4.07%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2023 is 28.12% vs 2.24% in Mar 2022
Consolidated Net Profit
YoY Growth in year ended Mar 2023 is 171.67% vs -23.86% in Mar 2022
About JBM (Healthcare) Ltd. 
JBM (Healthcare) Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






